Form 4 for OBIO Orchestra BioMed Holdings, Inc.

Accepted 2025-04-04 00:00:00 ET · period of report 2025-04-04 · accession 0001104659-25-032334 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-04-04	2025-04-04	OBIO	Hochman David P	See Remarks, Dir	A - Grant	$0.00	+98.3K	579.5K	+20%	$0
D	2025-04-04	2025-04-04	OBIO	Hochman David P	See Remarks, Dir	A - Grant	$0.00	+147.5K	147.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, par value $0.0001 per share ("Common Stock")	2025-04-04	A	A	98,333	$0.00	579,498	D	—	—	(F1) Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 33.33% of the shares will vest 24 months after April 4, 2025 (the "Issue Date"), (ii) 33.33% of the shares will vest 30 months after the Issue Date, and (iii) 33.34% of the shares will vest 36 months after the Issue Date, subject to the Reporting Person's continuous service through such dates.
2	Derivative	Stock Option (Right to Buy)	2025-04-04	A	A	147,500	$0.00	147,500	D	$2.76 · — to 2035-04-04	147,500 Common Stock	(F2) The stock options will vest as follows: (i) 36,875 of the stock options will vest on April 4, 2026 (the "Vesting Commencement Date") and (ii) the remaining 110,625 stock options will vest in equal installments every three months on the same day of the month as the Vesting Commencement Date, starting on July 4, 2026, subject to the Reporting Person's continuous service through such dates.